CHONDROITIN SULFATE REDUCES BOTH CARTILAGE VOLUME LOSS AND BONE MARROW LESIONS IN KNEE OA PATIENTS STARTING AS EARLY AS 6 MONTHS AFTER INITIATION OF THERAPY: A RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED PILOT STUDY USING MRI

被引：0
|
作者：
Wildi, Lukas [1 ]
Raynauld, Jean-Pierre [1 ]
Martel-Pelletier, Johanne [1 ]
Beaulieu, Andre [2 ]
Bessette, Louis [3 ]
Morin, Frederic [4 ]
Abram, Francois [5 ]
Dorais, Marc [6 ]
Pelletier, Jean-Pierre [1 ]
机构：
[1] Univ Montreal, Hosp Res Ctr, Osteoarthrit Res Unit, Montreal, PQ, Canada
[2] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada
[3] Grp Rech Rhumatol & Malad Osseuses, Ste Foy, PQ, Canada
[4] Ctr Rech Musculo Squelett, Trois Rivieres, PQ, Canada
[5] ArthroVision Inc, Montreal, PQ, Canada
[6] StatSci Inc, Notre Dame Lile Perro, PQ, Canada
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 15 条
  • [1] Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
    Wildi, Lukas Martin
    Raynauld, Jean-Pierre
    Martel-Pelletier, Johanne
    Beaulieu, Andre
    Bessette, Louis
    Morin, Frederic
    Abram, Francois
    Dorais, Marc
    Pelletier, Jean-Pierre
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 982 - 989
  • [2] TREATMENT WITH CHONDROITIN SULFATE REDUCES CARTILAGE VOLUME LOSS IN KNEE OA PATIENTS ASSESSED BY MRI: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED PILOT STUDY
    Pelletier, J. -P.
    Wildi, L. M.
    Raynauld, J. -P
    Beaulieu, A.
    Bessette, L.
    Morin, F.
    Abram, F.
    Dorais, M.
    Martel-Pelletier, J.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S143 - S143
  • [3] Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI
    Railhac, J-J.
    Zaim, M.
    Saurel, A-S.
    Vial, J.
    Fournie, B.
    CLINICAL RHEUMATOLOGY, 2012, 31 (09) : 1347 - 1357
  • [4] Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI
    J-J. Railhac
    M. Zaim
    A-S. Saurel
    J. Vial
    B. Fournie
    Clinical Rheumatology, 2012, 31 : 1347 - 1357
  • [5] Erratum to: Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI
    J-J. Railhac
    M. Zaim
    A-S. Saurel
    J. Vial
    B. Fournie
    Clinical Rheumatology, 2014, 33 : 1527 - 1527
  • [6] Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI (vol 31, pg 1347, 2012)
    Railhac, J-J.
    Zaim, M.
    Saurel, A-S.
    Vial, J.
    Fournie, B.
    CLINICAL RHEUMATOLOGY, 2014, 33 (10) : 1527 - 1527
  • [7] Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial
    Guangfeng Ruan
    Shiwen Yuan
    Aiju Lou
    Yingqian Mo
    Yuan Qu
    Dongmei Guo
    Shangqi Guan
    Yan Zhang
    Xiaoyong Lan
    Jun Luo
    Yifang Mei
    Hongwei Zhang
    Weirong Wu
    Lie Dai
    Qinghong Yu
    Xiaoyan Cai
    Changhai Ding
    BMC Musculoskeletal Disorders, 23
  • [8] Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial
    Ruan, Guangfeng
    Yuan, Shiwen
    Lou, Aiju
    Mo, Yingqian
    Qu, Yuan
    Guo, Dongmei
    Guan, Shangqi
    Zhang, Yan
    Lan, Xiaoyong
    Luo, Jun
    Mei, Yifang
    Zhang, Hongwei
    Wu, Weirong
    Dai, Lie
    Yu, Qinghong
    Cai, Xiaoyan
    Ding, Changhai
    BMC MUSCULOSKELETAL DISORDERS, 2022, 23 (01)
  • [9] IN A TWO-YEAR DOUBLE-BLIND RANDOMIZED CONTROLLED MULTICENTER STUDY, CHONDROITIN SULFATE WAS SIGNIFICANTLY SUPERIOR TO CELECOXIB AT REDUCING CARTILAGE LOSS WITH SIMILAR EFFICACYAT REDUCING DISEASE SYMPTOMS IN KNEE OSTEOARTHRITIS PATIENTS
    Pelletier, J. -P.
    Raynauld, J-P.
    Beaulieu, A.
    Bessette, L.
    Morin, F.
    de Brum-Fernandes, A. J.
    Abram, F.
    Dorais, M.
    Martel-Pelletier, J.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S155 - S156
  • [10] IN A 2-YEAR DOUBLE-BLIND RANDOMIZED CONTROLLED MULTICENTER STUDY, CHONDROITIN SULFATE WAS SIGNIFICANTLY SUPERIOR TO CELECOXIB AT REDUCING CARTILAGE LOSS WITH SIMILAR EFFICACY AT REDUCING DISEASE SYMPTOMS IN KNEE OSTEOARTHRITIS PATIENTS
    Pelletier, J. P.
    Raynauld, J. P.
    Beaulieu, A.
    Bessette, L.
    Morin, F.
    De Brum-Fernandes, A. J.
    Abram, F.
    Dorais, M.
    Martel-Pelletier, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 4 - 4
12